Models for the polymerization process involved in prion self-replication are well established and studied ([10, 13, 26]) in the case where the dynamics coefficients do not depend on the size of polymers. However, several experimental studies indicate that the structure and size of the prion aggregates are determinant for their pathological effect. This motivated the analysis in [4] where the authors take into account size dependent replicative properties of prion aggregates.
Introduction
The prion protein is known to be at the origin of fatal neurodegenerative diseases as Creutzfeldt-Jakob disease (CJD) in human and Bovine Spongiform Encephalopathy in cattle. Even though the detailed mechanism remains mostly unclear, a largely accepted hypothesis suggests the infectious agent is the misfolded form (called PrPsc) of the normal prion protein (PrPc). According to this protein-only hypothesis, abnormal PrPsc can convert PrPc by a still unknown autocatalytic process [25] . Very intringuing in this context is that prion infectious agent can exist under different strains. Prion strains have been initially distinguished by incubation periods and lesion profiles in congenic mice [3, 12] . Nowadays, a large body of literature suggests that differences between prion strains lie in the diversity of PrPsc structure, that can be stably and faithfully propagated (see [6, 21] for reviews). However, it remains poorly understood how these changes in the PrPsc conformation can account for their physiopathological effects [17] . Moreover, transmission of prion diseases between different mammalian species is almost systematically less efficient than within a single species [6] . This obstruction has been termed Species Barriers. Early studies argue that barrier resides in PrP primary structure difference between donor and recipient species [24] . However, BSE strain capability confirmed that different strains propagated in the same host may have completely different barriers to another species. Consequently, transmission barrier appears to depend on prion strain specificities [3, 7] . A critical challenge of prion biology consists in understanding how a diversity of strains may exist in the same host (expressing the same PrP molecule) and what structural basis of prion strains determines the strength of the species barrier.
As for many protein misfolding disorders (Alzheimer's disease, Parkinson's disease and many other), misfolded PrPsc has the ability to polymerize and form long aggregates called fibrils. Fibrils can be observed while the transconformation process arises at time and size scales mostly unaccessible to experiments. This is why mathematical models are useful to forecast consequences of modeling assumptions at that scale. Based on fibrilar aggregation, the model which seems by now broadly accepted is the one of nucleated polymerization. In this approach, PrPsc is considered to be a polymeric form of PrPc. Polymers can lengthen by addition of PrPc monomers, and they can replicate by splitting into smaller fragments [10, 13, 26] . It is worth noting that this model leads to an unimodal size distribution of PrP aggregates, which seems to be quite insensitive to small variations of parameters [27] . Greer et al. [14] recently improved the model and include a mean saturation effect by the whole population of polymers onto the lenghtening process (called general incidence), and polymer joining (through a Smoluchowski coagulation equation). In all these models, each aggregate has the same behaviour, regardless to its size. However, recent experimental analysis of relation between infectivity and size distribution of PrPsc aggregates (for PrPsc purified from infected brain [28] or for PrPsc produced by PMCA [31, 32] , a technique which alternates PrPsc aggregates growth during incubation phases and aggregates fragmentation during sonication phases) contradicts this uniform behaviour of PrPsc aggregates. In addition, some complexity in the PrPsc aggregate size distribution is more likely to occur within the real process [28] . This leads to consider a model which can reproduce such a behaviour, and the simplest modeling assumption consists in introducing extension rates that depend on the fibril size [4] .
This motivates to use the following model for prion polymerization where V (t) denotes the quantity of PrPc (normal protein), x ∈ (0, +∞) denotes the size of aggregates and u(x, t) the density of aggregates of size x,
together with appropriate initial conditions (u 0 , V 0 ). This is a well established family of models used for describing aggregation, fragmentation in polymers as well as natural production of monomers V (t) (possibly already small aggregates of PrPsc molecules) [10, 13, 14, 16, 26, 29] . Compared to earlier completely discrete models, it has the advantage of taking into account two scales; (i) a small scale (of the order of several PrPsc molecules) for continuous aggregation represented by [39] .
the x-derivative and (ii) a large scale for the total length of the fibrils represented by the integral term. It can be derived through an asymptotic analysis departing from the single PrPsc scale with a discrete model. See [8, 11, 15] . Well-posedness, in the class of weak solutions, has been studied in great generality by [16, 29] . Strong solutions to (1) are built by [10] in the case of 'constant coefficients', i.e., where τ , µ are constant, β(x) = β 0 x and κ(x, y) = 1 y 1 (0≤x≤y) . The transport term accounts for the growth in size of polymers: their size grows with the rate V (t)τ (x), proportional to the available PrPc molecules V (t), with an aggregation ability depending on the size of the polymer (a conceivable hypothesis being that their size confers them a peculiar geometry affecting the autocatalytic process). The fragmentation rate, for a polymer of size y, is β(y) > 0. The repartition of the two fragments of (smaller) sizes x and y − x is given by κ(x, y) ≥ 0. It should thus satisfy the two usual laws [22] expressing that the number of fragments increases but with constant total molecular mass (recall the factor 2 in the right hand side of (1)):
This implies that this dynamical system is equipped with two natural balance laws
In this study, we aim to continue the work initiated in [4] . Amongst other things, a convincing mathematical model has to reproduce the unusual kinetics of PrPsc accumulation and to be compatible with the strain phenomenon.
In section 2, we address the first question. PrPsc accumulation in brain follows an exponential growth until the death, whereas it invariably reaches a plateau concentration in tissues outside the central nervous system [34, 35] . Thus, the mathematical system must have at least two steady state (one corresponding to Silveira. For details, see [28] ). Size-distribution of PrPsc aggregates in a whole infected hamster brain (solid line) and relative specific infectivity of each fraction containing PrPsc aggregates with respect to their size (dotted line). The former corresponds to the quantity xu(x, t), and the latter represents a bellshaped converting rate τ (x). These are however undirect measurements after purification and sonication (i.e. fragmentation induced by ultrasound) . (Center) Size distribution obtained by solving numerically (6) for a suitable bell-shaped converting rate τ (x) (dotted line), the non-zero steady state solution presents a bimodal shape (solid line). (Right) Size distribution corresponding to 'constant coefficients' in model (1) .
the healthy state, and one corresponding to the infection). The question of the existence and the stability of these steady states has been extensively studied in the case of 'constant coefficients' in [10, 13, 14, 26] . Here, as in [4, 8, 9] , we are interested in non-constant rates. In such case, the attractivity of the healthy steady state is proved in [4] when λ is small and the infectious steady state does not exist. When the infectious steady state exists, it is not known if it is attractive or if other dynamics such as periodic solutions can exist. Although oscillations are not expected to occur according to experiments, and have not been observed in numerical simulations so far, we are not able to exclude them at the moment. Our first purpose is to give an improved estimate showing that (u ≡ 0, V = V ) is repulsive in the infectious case.
The second question concerning strain mechanism is addressed in section 3. Our purpose is to indicate a route to study possible relations between PrPsc aggregate size distributions as obtained from the model (1) with 'non-constant coefficients' (especially non-constant elongation rate τ ) and the strain phenomena described previously. It is based on the dynamical capability of this nonlinear system to generate size repartitions with high complexity and specific properties, notably the bimodal repartition depicted in Figure 2 .
Mathematical results

Description of the associated eigenproblem
The eigenproblem associated with the aggregation-fragmentation equation in (1) is useful for the mathematical analysis. For a given V > 0, we denote by Λ(V) the first eigenvalue and by (U (V; x), ϕ(V; x)) resp. the eigenfunction and the adjoint eigenfunction, that are the solutions to 
We remind the reader that the former (4) defines the (opposite of) malthusian factor Λ(V), and expresses the fact that whenever the level of PrPc V is fixed the population of aggregates grows with the exponential rate exp(−Λ(V)t) and with the asymptotic size-distribution U(V; x) (see below for further discussion related to the stationary states). The latter (5) has less clear biological interpretation however. It can be viewed as the natural measure that yields an effective mass conservation for the corresponding aggregation-fragmentation Markov process [22] . Although the solutions of (4)- (5) come formally from the Krein-Rutman theorem, the lack of compactness in the problem requires some specific proof (and technical assumptions on the coefficients). In particular we shall pay much attention to the competition between the growth term ∂ x (τ (x)U(x)) which pushes the distribution away from small sizes and the fragmentation term β(x)U(x) − 2 ∞ x β(y)κ(x, y)U(y) dy which drives the distribution back to small sizes. We refer the interested reader to [9] for existence and assume throughout this paper that the coefficients satisfy the following main conditions:
associated with a couple of technical assumptions.
Several analytical examples are presented in [4] where it appears naturally that Λ(V) should be decreasing. Even though no general proof is available as today, it holds true by continuity when the coefficients do not differ too much from these examples. Also numerics indicate that this property might be true for a large class of transconformation rates τ (x), including bell-shaped rates, as one can see in Figure 3 .
Following [4] , the steady states to (1) can now be reformulated in terms of the eigenelements. The so-called 'healthy steady state' corresponds to (u ≡ 0, v = V := λ/γ). More interesting, the 'infectious' steady state (u ∞ , V ∞ ) can exist and corresponds, in (4)- (5) , to the relations
Accordingly to the above interpretation, it corresponds to a level of PrPc yielding a zero malthusian growth for the aggregates, which is an obvious necessary condition for having a stationary state. Furthermore the profile of the size-distribution at equilibrium is given by the eigenfunction U(V ∞ ; x).
Such a steady state only exists if the prion production λ is high enough so as to choose ∞ which satisfies the third condition, namely
The question of the stability of these steady states has been extensively studied in the case of 'constant coefficients', i.e., where τ , µ are constant β(x) = β 0 x and κ(x, y) = 1 y 1 (0≤x≤y) in [10, 13, 14, 26] . Then the system can be reduced to a three by three system of ordinary differential equations on
It turns out that the condition (7) is sharp and when λ is small only the healthy steady state exists and is stable. If λ is large enough so that the other steady state exists, it is globally attractive. Here, we are interested in non-constant rates.
Analysis of stability
Several stability results are proved in [4] . When λ is small the only steady state to (1) is (0, V ), the healthy state, that is proved that it is globally attractive; for any initial data we have u(t) → 0 as t → 0 in L 1 . In the case when there is another steady state (u ∞ , V ∞ ), the infectious state, it is proved that trajectories cannot come close to the healthy state (persistency). But it is not known if it is attractive or if other dynamics as periodic solutions can exist.
We complete the result in [4] by removing a size condition on some parameters of the system (see below), and replacing it with an assumption on the global boundedness of the number and mean size of aggregates. The main advantages are twofold: this new criterion has a very clear biological interpretation, and moreover it can be obtained through independent estimates as in Theorem 2.1.
In order to state our new persistency result we first prove a uniform bound
The condition on β involves some smallness and we do not know if it can be improved. However it is clear that the mortality rate µ should be large enough otherwise the constant production of monomers is not balanced by any degradation and the system tends to infinity. On the other hand, the case when β(x) has sublinear growth is also of interest and corresponds to a well established theory, see [9] .
Proof : We combine the two balance laws (3) and for a > 0 to be chosen later on, we calculate
From our assumption on β, we obtain that
We now choose a such that aC β < µ/2, and we get for some b > 0 small enough so that
Thanks to the Gronwall lemma, this differential inequality proves the announced boundedness.
Our second result improves the persistency argument in [4] and still uses a duality method based on the weight ϕ = ϕ(V ; ·). We assume that there are two constants
This condition generally holds true because ϕ grows at most linearly at infinity according to general structure properties proved in [20, 22, 23] and related to the assumption (2). We have Theorem 2.2 : We assume that Λ(V ) < 0, V (0) ≤ V and that ∞ 0 (1+x)u(t, x)dx is uniformly bounded. Then the system remains away from the steady state (u ≡ 0, V ). More precisely we have:
In comparison with [4, Theorem 3] , the peculiar size condition on the coefficients, namely K 1 V < Λ(V ) + γ (where K 1 is introduced in (8), has been removed and replaced by the boundedness of the number and size of the polymers.
Proof : For the sake of clarity we introduce the quantities 0 ≤ v(t) = V −V (t) ≤ V and w(t) = ∞ 0 ϕ(x)u(x, t)dx. Testing the system (1) against ϕ(x) (5), it implies after integration by parts:
Notice also that v(t) cannot vanish in finite time.
Next
and we now choose α large enough so that δ = αγ + Λ(V ) − K 1 V > 0. This leads to the system of differential inequalities:
We denote by w = lim sup t→∞ w(t), which is finite thanks to our global boundness on u(x, t) because ϕ has sublinear growth at infinity. Then, the first differential inequality on y(t) tells us that,
And then, we deduce from the second inequality that lim inf t→∞ w(t) ≥ |Λ(V )| α K −α 1 y and the proof is completed. Notice that we need the a priori knwoledge that w(t) is upper bounded in order to obtain the lower bound from the the system (9). And such a property is not a consequence of the dynamics on (y, w) only. This means that some information is lost (as the mortality rate) when reducing the infinite dimensional system to these two quantities and the upper bound should come from another stage as we mentioned earlier (Theorem 2.1 for instance).
Dynamics and strain phenomena
It has been suggested that less stable prion strain are more infectious, as judged by their shorter incubation times [17] . In addition, most infectious particles (fractionnated by sedimentation) seem to be smaller for fast strains than for slow strains [38] . However, how the PrPsc conformation of a specific strain influences its replicative properties remains unclear. In this section, we aim at studying how of a slight change in the replicative parameters can reproduce or predict strains properties. We are mainly interested in PrPsc aggregate size distribution, which could be used to study strain mechanisms. Indeed, analysis of the dynamics of model (1) initiated in [4] emphasizes the importance of the size distribution of PrPsc aggregate, which seems to be very informative on prion replication mechanism. Notably, it has been shown that different size repartitions resulting from different replicative parameters can play a role in the strain adaptation mechanism.
Our approach is based both on analysis through the eigenvalue problem (4),(5) and on direct numerical simulations of the temporal dynamics.
Numerics
Parameters of the nucleated polymerization model for prion growth have been estimated for the 'constant parameters model' from experimental data and are available in the literature, see [13, 27] and the references therein. The parameter values used in the sequel have been quoted from Rubenstein et al. [27] . Unless explicitly mentioned, they are: λ = 2400 per day, γ = 4 per day, µ 0 = .05 per day, and β(x) = β 0 x with β 0 = 0.03 per day.
The real conversion function is still unkown. We test two different functions, which represent idealized extreme cases:
• a bell-shape function, accounting for the case of the infectious particles are concentrated around one specific size. The conversion function τ (x) is the sum of a basal rate τ 0 = .001 and a gaussian bell centered on m:
with a magnitude A to be chosen by several orders of magnitude above τ 0 .
• a sigmoidal shape, when aggregates larger than a critical size are identically more infectious than smaller polymers. Then the conversion function τ (x) is given by:
Throughout the rest of this paper, the simulations assume an initial PrPc population V (0) = V = λ/γ (corresponding to the healthy steady state because we assume inoculation in an healthy animal) and an initial PrPsc distribution which is a small perturbation of the zero steady state, given by u(x, 0) = 0.5x 2 /(1 + x 4 ).
Effects of the conversion rate
Differently shaped size repartition of the conversion rate greatly affects the PrPsc agregates size distribution [4] . We test here the situation where changes in conformation do not lead to a completely different profile of converting activity, but only a change of either the magnitude of the conversion or the location of the most infectious particles. For the experiments depicted in figures 4 and 5, varying parameters acts upon the kinetics of PrPsc accumulation as follows: the higher the transconformation rate are or the smaller the most converting particles are, the faster the PrPsc accumulates, and thus, the shorter the incubation time seems to be. In particular, this implies that a fast strain could be able to fix and transconform PrPc either with great efficiency or by smaller aggregates (or both). Interestingly, our simulations also predict changes in the size-distribution of PrPsc, whose variations are specific of the varying parameters.
In the case of a bell-shaped conversion rate, we also have tested the effect of the thightness of the converting peak, by studying the dominant eigenvalue. Indeed, when we focus on the exponential growth of PrPsc (as is it the case in the brain but corresponds only to the early stages of accumulation in the spleen), the eigenvalue problem can be used during the initial phase of exponential growth (occuring at least in the diseased brains). We assume below that V > V ∞ according to (7) , that Λ(V ) is a decreasing function so that instability of the healthy state holds true as proved in [4] . This holds for the choice of coefficients mentioned above. We may assume that V (t) remains close enough to V because u(x, t) dynamics undergoes an exponential growth phase, while the polymerization behaves following a linear problem. Actually the second equation in (1) is decoupled from the first one at the first order of approximation. The dominant eigenvalue −Λ(V ) thus measures the exponential growth of the PrPsc total population (see [22] for a mathematical formulation of this fact using the generalized relative entropy). Several transconformation rates τ (x) -being the same basal rate τ 0 combined with a more and more concentrated gaussian bell are tested -and the corresponding growth rate in the exponential phase −Λ(V ) are computed numerically ( Figure 6 ). Interestingly, the results exhibit a best compromise around α ≈ 0.01 (intermediate concentrations of the peak). Thus, according to this model the optimal conditions for PrPsc accumulation in the exponential expansion phase do not correspond to a very thin peak.
Effects of the fragmentation rate
As suggested in [17, 28] , prion strains can differ in their stability. Here, we make the assumption that the stability of a strain is only represented by the framentation rate β. However, it could also be interesting to study the effect of the degradation rate µ. According to numerical experiment depicted in Figure 7 , increasing the fragmentation rate leads to a faster PrPsc accumulation for a bell-shaped converting rate τ as for a sigmoidal τ . However, for a sigmoidal τ with a higher critical threshold, the inverse effect is observed, due to the fact that small aggregates are less able to convert PrPc than larger PrPsc polymers, and then multiplying the number of small particles does not compensate for the loss of conversion activity any more. Surprisingly enough, we also can observe that when the fragmentation accelerates the accumulation of PrPsc, this faster accumulation leads to a lower level of total PrPsc amount at the plateau.
Conclusion and perspectives
We have continued the analysis in [4] concerning size dependent polymerization rates in the standard model (1) for prion PrPsc self-replication. The interesting situation is when the prion production rate is large enough to permit an infectious steady state. Analytical study of its instability remains an open problem (see [10, 13, 14, 26] for the 'constant coefficients' case) but we could improve a previous result showing that the healthy state is unstable and solutions remain globally bounded. As previously but in a more general framework, we confirm that the amount of PrPc is critical for the development of prion diseases. This is in accordance with well-known experimental results, where PrP-KO mice cannot be infected [33] . However, this result may have wider implications for many other neurodegenerative diseases. Indeed, numerous pathologies (such as Alzheimer's disease, Parkinson's disease and Hungtington's disease) are characterized by the aberrant polymerization and accumulation of misfolded proteins. Many evidences show that they can be induced in transgenic models (see [36, 37] for review). Thus, whether these misfolding protein disorders are transmissible or not is currently widely debated. Our results suggest that the bioavailability of the amyloid precursor is critical for transmissibility. This is consistent with the fact that, in prion diseases, prion precursor is the protein itself and naturally present in large amount in neurons, whereas in Alzheimer's disease, Abeta is only a minor proteoteolytic cleavage product of the Amyloid Precursor Protein (APP). V. Calvez, N. Lenuzza, M. Doumic, J-P. Deslys, F. Mouthon and B. Perthame This necessary condition of PrPc bioavaibility is however insufficient to explain strain mechanisms, since species expressing PrPc can be infected only by specific strains. Thus additional constraints are likely to be required for prion strain transmission and propagation. Such constraints can be purely physicochemical, due to one peculiar structure of prion aggregates. Indeed, a large body of literature suggests that differences between prion strains lie in the diversity of structures of PrPsc aggregates that can be stably and faithfully propagated [1, 2, 5, 6, 17, 21, 30] . However, it remains poorly understood how these changes in the conformation of PrPsc aggregates can account for their physiopathological effects and their relationship with the host [17] . Although our model does not separate the host contribution from the strain contribution, it represents on the contrary the relationship between host and pathogen and it allows studying which elementary replicative parameter is critical in strain propagation.
Among the attempted biochemical characterisation of prion strains, a relationship was found between the relative stability values of PrPsc aggregates [17] or level of aggregation [1] and incubation times, indicating that less stable prions are more infectious, as judged by their shorter incubation times. This is presumably because unstable prions fragment more easily, giving rise to smaller aggregates of PrPsc that are more infectious than larger ones. Our model agrees with these observations for a bell-shaped conversion rate, since increasing the fragmentation (bottom) (Left) Time evolution of total PrPsc (abscissa = Time (in day) ; ordinate = PrPsc total amount) (Right) Normalized PrPsc aggregates size distribution at t1 = 96 days (for τ 1 ), t2 = 20 days (for τ 2 ) and t3 = 60 days (for τ 3 ) corresponding to the exponential growth of PrPsc. The distributions are normalized by the total number of PrPsc aggregates (abscissa = PrPsc aggregates size; ordinate = PrPsc aggregates number).
rate β 0 leads to a faster PrPsc accumulation. Inverse results can be obtained for some sigmoidal conversion rates. It does not immediately means that a sigmoidal conversion rate is unrealistic, since this result strongly depends on the size distribution of the fragmentation rate. However, it emphasizes the need for precisely monitoring the fragmentation rate, which might depend on the PrPsc aggregate size in a more complex manner than the linear dependence supposed here.
We also have investigated the implications of varying the conversion rate: do different strain conformations lead to a more efficient fixation and conversion by the same aggregates or do they lead to different most converting particles? Our numerical simulations alone do not answer to this question, but interestingly, they show that whereas changing parameters leads to similar effects on PrPsc accumulation kinetics, the resulting size-distribution variations are different. Thus the achievement of experimental size-distribution of PrPsc aggregates for many prion strains could therefore allow to better understand the molecular mechanisms involved in prion strain phenomenon.
To conclude, this work completes the study initiated in [4] , notably in studying strain phenomenon. It emphasizes the potential role of PrPsc aggregates size distribution, which could be a signature of prion strain converting abilities. The next step of our work is to approximate faithfully the inverse problem in order to obtain the size dependence of the transconformation rate from the distribution of PrPsc for several strains. This knowledge is a critical step for experimental approaches of prion infectivity investigation like PMCA. Indeed, we have observed several times the existence of an optimal converting rate for PrPsc accumulation (see for instance the tightness in the case of a bell-shaped converting rate), which means that only slight changes in the replicative parameters can dramatically influence the kinetics of PrPsc accumulation. It could explain the sensitivity of PMCA to experimental procedures. Complete understanding of how the PrPsc accumulation of a given strain depends on their replicative parameters could help to optimize strain specific PMCA protocols.
